Prostate Cancer

18 F-labeled 1,2,3-triazole-linked Glu-urea-Lys-based PSMA ligands have good pharmacokinetic properties for positron emission tomography imaging of prostate cance. September 24, 2020

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. September 24, 2020

Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study. September 24, 2020

Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer. September 24, 2020

Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening. September 24, 2020

Health-Related Quality of Life and Survival in Prostate Cancer Patients in a Real-World Setting. September 23, 2020

Transperineal versus transrectal targeted biopsy with use of electromagnetically-tracked MR/US fusion guidance platform for the detection of clinically significant prostate cancer. September 23, 2020

Sudden PSA rise to ≥20 ng/ml and prostate cancer diagnosis in the United States: A population-based study. September 23, 2020

Seminal vesicle invasion combined with extraprostatic extension is associated with higher frequency of biochemical recurrence and lymph node metastasis than seminal vesicle invasion alone: Proposal for further pT3 prostate cancer subclassification. September 23, 2020

Senescence and castration resistance in prostate cancer: A review of experimental evidence and clinical implications. September 23, 2020

Dissemination of Misinformative and Biased Information about Prostate Cancer on YouTube. September 22, 2020

Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805). September 22, 2020

Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates. September 22, 2020

Immune signature driven by ADT-induced immune microenvironment remodeling in prostate cancer is correlated with recurrence-free survival and immune infiltration. September 22, 2020

Impact of organ confined prostate cancer treatment on quality of life. September 22, 2020

Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey. September 22, 2020

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer September 21, 2020

miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer. September 21, 2020

Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. September 21, 2020

Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-Resistant Prostate Cancer: A Phase 1 Study of Concurrent Enzalutamide and Crizotinib. September 21, 2020

Page 1 of 1104